Studies on atherosclerosis have discovered that nontransferrin bound serum iron (NTBI) excess might hasten the progression of atherosclerosis by triggering vascular cell death, vascular endothelial cell activation, and a significant increase in MCP-1-mediated monocyte recruitment [22]. The gene discussed is CCL2; the disease is atherosclerosis.